VERO Venus Concept Inc. logo

VERO Venus Concept Inc.

Healthcare
$0.31+2.64%ClosedMarket Cap: $578,187

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.22

P/S

0.01

EV/EBITDA

-0.60

DCF Value

$-290.95

FCF Yield

-3588.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

64.4%

Operating Margin

-59.0%

Net Margin

-92.8%

ROE

-2268.3%

ROA

-88.6%

ROIC

-93.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$13.8M$-22.6M$
Q2 null$15.7M$-11.7M$
Q1 null$13.6M$-12.4M$
Q4 null$15.8M$-8.0M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Madryn Asset Management, LP10 percent owner
BuyMon Mar 30
Madryn Asset Management, LP10 percent owner
BuyMon Mar 30
Madryn Asset Management, LP10 percent owner
BuyMon Mar 30
Madryn Asset Management, LP10 percent owner
BuyMon Mar 30
Madryn Asset Management, LP10 percent owner
BuyMon Mar 30

Latest News

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

CA

Exchange

Beta

-0.06

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.

Peers